Last reviewed · How we verify

NCT05201339

Effect of Head-neck Rotation on I-gel™ Insertion

Completed NA Last updated 3 October 2024
What this trial tests

NA trial testing Standard method in Supraglottic Airway Device in 172 participants. Completed in 2 June 2023.

Timeline
25 February 2022
Primary endpoint
2 June 2023
2 June 2023

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment172
Start date25 February 2022
Primary completion2 June 2023
Estimated completion2 June 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Supraglottic Airway Device or Intubation; Difficult or Failed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison between head rotation and standard techniques for i-gel™ insertion: a randomized controlled trial.
    Lee S, Nam K, Park SJ, Ju JW, et al · · 2024 · cited 1× · PMID 38987667 · DOI 10.1186/s12871-024-02621-7

Verify or expand the search:

Other trials of Standard method

Trials testing the same drug.

Other recruiting trials for Supraglottic Airway Device

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05201339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing